Rhythm Biosciences Ltd. ( (AU:RHY) ) has shared an announcement.
Rhythm Biosciences Ltd. announced a proposed issue of securities, specifically options expiring on March 31, 2026, with an exercise price of $0.20. This issuance, involving a total of 401,716 securities, is aimed at raising capital to support the company’s operational and strategic initiatives. The announcement reflects the company’s ongoing efforts to strengthen its financial position and enhance its market presence in the biotechnology sector.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd. operates in the biotechnology industry, focusing on the development and commercialization of medical diagnostics. The company primarily offers products aimed at detecting and monitoring diseases, with a particular emphasis on cancer diagnostics.
YTD Price Performance: -26.67%
Average Trading Volume: 258,686
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$19.13M
See more insights into RHY stock on TipRanks’ Stock Analysis page.